References:
  1. Voss S, Campanella C, Burri M, Trenkwalder T, Sideris K, Erlebach M, Ruge H, Krane M, Vitanova K, Lange R. Anatomical reasons for failure of dual-filter cerebral embolic protection application in TAVR: A CT-based analysis. J Card Surg. 2021 Dec;36(12):4537-4545. doi: 10.1111/jocs.16025. Epub 2021 Sep 27. PMID: 34580919.
  2. Voss S, Schechtl J, Nöbauer C, Bleiziffer S, Lange R. Patient eligibility for application of a two-filter cerebral embolic protection device during transcatheter aortic valve implantation: does one size fit all? Interact Cardiovasc Thorac Surg. 2020 Apr 1;30(4):605-612. doi: 10.1093/icvts/ivz306. PMID: 31904829.
  3. Demir OM, Iannopollo G, Mangieri A, Ancona MB, Regazzoli D, Mitomo S, Colombo A, Weisz G, Latib A. The Role of Cerebral Embolic Protection Devices During Transcatheter Aortic Valve Replacement. Front Cardiovasc Med. 2018 Oct 23;5:150. doi: 10.3389/fcvm.2018.00150. PMID: 30406115; PMCID: PMC6205957.
  4. Giustino G, Mehran R, Veltkamp R, Faggioni M, Baber U, Dangas GD. Neurological Outcomes With Embolic Protection Devices in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. JACC Cardiovasc Interv. 2016 Oct 24;9(20):2124-2133. doi: 10.1016/j.jcin.2016.07.024. PMID: 27765306.
  5. Van Mieghem NM, Schipper ME, Ladich E, Faqiri E, van der Boon R, Randjgari A, Schultz C, Moelker A, van Geuns RJ, Otsuka F, Serruys PW, Virmani R, de Jaegere PP. Histopathology of embolic debris captured during transcatheter aortic valve replacement. Circulation. 2013 Jun 4;127(22):2194-201. doi: 10.1161/CIRCULATIONAHA.112.001091. Epub 2013 May 7. PMID: 23652860.